{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T11:55:20Z","timestamp":1774698920441,"version":"3.50.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.nbd.2025.106803","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T19:41:24Z","timestamp":1736538084000},"page":"106803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Peripherally administered TNF inhibitor is not protective against \u03b1-synuclein-induced dopaminergic neuronal death in rats"],"prefix":"10.1016","volume":"206","author":[{"given":"Josefine R.","family":"Christiansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara A.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Szymkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Jakobsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mal\u00fa G\u00e1mez","family":"Tansey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Romero-Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2025.106803_bb0005","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10787-023-01192-2","article-title":"A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson\u2019s disease: beneficial or detrimental effects","volume":"31","author":"Alrouji","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.nbd.2025.106803_bb0010","doi-asserted-by":"crossref","first-page":"15161","DOI":"10.1073\/pnas.96.26.15161","article-title":"Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators","volume":"96","author":"An","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2025.106803_bb0015","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1046\/j.1471-4159.2003.01742.x","article-title":"Co-ordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines","volume":"85","author":"Baptista","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.106803_bb0020","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3233\/JPD-140410","article-title":"Peripheral administration of the selective inhibitor of soluble tumor necrosis factor (TNF) XPro(R)1595 attenuates nigral cell loss and glial activation in 6-OHDA hemiparkinsonian rats","volume":"4","author":"Barnum","year":"2014","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.nbd.2025.106803_bb0025","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1093\/brain\/awr199","article-title":"Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination","volume":"134","author":"Brambilla","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.106803_bb0030","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nbd.2006.08.021","article-title":"Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: is this the target for Parkinson\u2019s disease?","volume":"25","author":"Chu","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106803_bb0035","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/cne.20828","article-title":"Nurr1 in Parkinson\u2019s disease and related disorders","volume":"494","author":"Chu","year":"2006","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2025.106803_bb0040","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1523\/JNEUROSCI.5427-08.2009","article-title":"Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy","volume":"29","author":"Chung","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106803_bb0045","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12974-014-0203-6","article-title":"Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia","volume":"11","author":"Clausen","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2025.106803_bb0050","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.nbd.2009.11.018","article-title":"Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia\/macrophage activation","volume":"37","author":"De Lella Ezcurra","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106803_bb0055","doi-asserted-by":"crossref","DOI":"10.1042\/NS20220063","article-title":"Cytokine activity in Parkinson\u2019s disease","volume":"7","author":"Dzamko","year":"2023","journal-title":"Neuron. Signali."},{"key":"10.1016\/j.nbd.2025.106803_bb0060","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuroscience.2014.10.028","article-title":"Inflammation is genetically implicated in Parkinson's disease","volume":"302","author":"Dzamko","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2025.106803_bb0065","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12974-017-0935-1","article-title":"Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson\u2019s disease","volume":"14","author":"Eidson","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2025.106803_bb0070","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.expneurol.2013.03.017","article-title":"Chronic intranasal deferoxamine ameliorates motor defects and pathology in the alpha-synuclein rAAV Parkinson\u2019s model","volume":"247C","author":"Febbraro","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2025.106803_bb0075","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nbd.2013.03.014","article-title":"Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson\u2019s disease","volume":"56C","author":"Febbraro","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106803_bb0080","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41531-023-00606-w","article-title":"Sex-dimorphic neuroprotective effect of CD163 in an \u03b1-synuclein mouse model of Parkinson\u2019s disease. Npj","volume":"9","author":"Ferreira","year":"2023","journal-title":"Parkinson\u2019s Disease."},{"key":"10.1016\/j.nbd.2025.106803_bb0085","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","article-title":"Neuropathology of Parkinson\u2019s disease","volume":"55","author":"Forno","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2025.106803_bb0090","article-title":"Lack of neuroprotection after systemic administration of the soluble TNF inhibitor XPro1595 in an rAAV6-\u03b1-Syn+PFFs-induced rat model for Parkinson\u2019s disease","author":"Fredlund","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.nbd.2025.106803_bb0095","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106803_bb0100","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0092-8674(95)90192-2","article-title":"The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor","volume":"83","author":"Grell","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2025.106803_bb0105","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1073\/pnas.95.2.570","article-title":"The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor","volume":"95","author":"Grell","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2025.106803_bb0110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2818.1987.tb02837.x","article-title":"The efficiency of systematic sampling in stereology and its prediction","volume":"147","author":"Gundersen","year":"1987","journal-title":"J. Microsc."},{"key":"10.1016\/j.nbd.2025.106803_bb0115","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/mt.2010.217","article-title":"Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson\u2019s disease","volume":"19","author":"Harms","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2025.106803_bb0120","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.virol.2007.10.007","article-title":"Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, and 9 in rat neurons and glia in vitro","volume":"372","author":"Howard","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.nbd.2025.106803_bb0125","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1093\/hmg\/ddu151","article-title":"Inhibition of soluble tumor necrosis factor is therapeutic in Huntington\u2019s disease","volume":"23","author":"Hsiao","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.nbd.2025.106803_bb0130","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","article-title":"Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains","volume":"106","author":"Imamura","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2025.106803_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105027","article-title":"Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson\u2019s disease: a case series","volume":"144","author":"Joers","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106803_bb0140","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.87455","article-title":"Therapeutic inhibition of soluble brain TNF promotes remyelination by increasing myelin phagocytosis by microglia","volume":"2","author":"Karamita","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.nbd.2025.106803_bb0145","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1998.6848","article-title":"Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat","volume":"152","author":"Kirik","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2025.106803_bb0150","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1523\/JNEUROSCI.20-12-04686.2000","article-title":"Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson\u2019s model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system","volume":"20","author":"Kirik","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106803_bb0155","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1750-1326-5-43","volume":"5","author":"Koprich","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2025.106803_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/biom13060977","article-title":"Sex and age differences in a progressive Synucleinopathy mouse model","volume":"13","author":"Lamontagne-Proulx","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.nbd.2025.106803_bb0165","article-title":"Selective inhibition of soluble TNF using XPro1595 improves hippocampal pathology to promote improved neurological recovery following traumatic brain injury in mice","author":"Larson","year":"2022","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.nbd.2025.106803_bb0170","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.parkreldis.2020.11.011","article-title":"Increased microglial activation in patients with Parkinson disease using [(18)F]-DPA714 TSPO PET imaging","volume":"82","author":"Lavisse","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2025.106803_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047387","article-title":"Non-motor symptoms in patients with Parkinson's disease - correlations with inflammatory cytokines in serum","volume":"7","author":"Lindqvist","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2025.106803_bb0180","doi-asserted-by":"crossref","first-page":"17510","DOI":"10.1073\/pnas.0405313101","article-title":"Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson\u2019s disease","volume":"101","author":"Lo Bianco","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2025.106803_bb0185","article-title":"Selective inhibition of soluble tumor necrosis factor alters the Neuroinflammatory response following moderate spinal cord injury in mice","volume":"12","author":"Lund","year":"2023","journal-title":"Biology (Basel)."},{"key":"10.1016\/j.nbd.2025.106803_bb0190","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.nbd.2017.02.010","article-title":"Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice","volume":"102","author":"MacPherson","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106803_bb0195","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1165\/rcmb.2010-0512OC","article-title":"Allergic lung inflammation is mediated by soluble tumor necrosis factor (TNF) and attenuated by dominant-negative TNF biologics","volume":"45","author":"Maillet","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.nbd.2025.106803_bb0200","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.nbd.2006.04.007","article-title":"Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression","volume":"23","author":"Maingay","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106803_bb0205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nbd.2009.01.006","article-title":"Inhibition of soluble TNF signaling in a mouse model of Alzheimer\u2019s disease prevents pre-plaque amyloid-associated neuropathology","volume":"34","author":"McAlpine","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106803_bb0210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1742-2094-5-45","article-title":"TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease","volume":"5","author":"McCoy","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2025.106803_bb0215","doi-asserted-by":"crossref","first-page":"9365","DOI":"10.1523\/JNEUROSCI.1504-06.2006","article-title":"Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson\u2019s disease","volume":"26","author":"McCoy","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106803_bb0220","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/mt.2008.146","article-title":"Intranigral lentiviral delivery of dominant-negative TNF attenuates neurodegeneration and behavioral deficits in hemiparkinsonian rats","volume":"16","author":"McCoy","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2025.106803_bb0225","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/978-1-4419-6612-4_56","article-title":"TNF: a key neuroinflammatory mediator of neurotoxicity and neurodegeneration in models of Parkinson\u2019s disease","volume":"691","author":"McCoy","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.nbd.2025.106803_bb0230","first-page":"474","article-title":"The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson\u2019s disease","volume":"51","author":"Menza","year":"2010","journal-title":"Psychosomatics"},{"key":"10.1016\/j.nbd.2025.106803_bb0235","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","article-title":"Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients","volume":"165","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2025.106803_bb0240","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0304-3940(99)00388-2","article-title":"Increase in level of tumor necrosis factor (TNF)-alpha in 6-hydroxydopamine-lesioned striatum in rats without influence of systemic L-DOPA on the TNF-alpha induction","volume":"268","author":"Mogi","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2025.106803_bb0245","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1016\/j.febslet.2014.05.046","article-title":"Tumour necrosis factor alpha-induced neuronal loss is mediated by microglial phagocytosis","volume":"588","author":"Neniskyte","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2025.106803_bb0250","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12974-014-0159-6","article-title":"Central but not systemic administration of XPro1595 is therapeutic following moderate spinal cord injury in mice","volume":"11","author":"Novrup","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2025.106803_bb0255","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1086\/597204","article-title":"Dominant-negative tumor necrosis factor protects from Mycobacterium bovis Bacillus Calmette Guerin (BCG) and endotoxin-induced liver injury without compromising host immunity to BCG and mycobacterium tuberculosis","volume":"199","author":"Olleros","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.nbd.2025.106803_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710126","article-title":"Neuropathology of the basal ganglia in SNCA transgenic rat model of Parkinson\u2019s disease: involvement of Parvalbuminergic interneurons and glial-derived neurotropic factor","volume":"23","author":"Paldino","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.106803_bb0265","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.nbd.2025.106803_bb0270","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1038\/s41598-017-06724-9","article-title":"Early synaptic dysfunction induced by alpha-synuclein in a rat model of Parkinson\u2019s disease","volume":"7","author":"Phan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2025.106803_bb0275","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.celrep.2018.07.017","article-title":"Huntingtin aggregation impairs autophagy, leading to Argonaute-2 accumulation and global MicroRNA dysregulation","volume":"24","author":"Pircs","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2025.106803_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106511","article-title":"Diet-induced metabolic and immune impairments are sex-specifically modulated by soluble TNF signaling in the 5xFAD mouse model of Alzheimer\u2019s disease","volume":"196","author":"Rodrigues","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106803_bb0285","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12974-020-01776-7","article-title":"Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson\u2019s disease brain","volume":"17","author":"Rostami","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2025.106803_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108895","article-title":"TNF-\u03b1 and \u03b1-synuclein fibrils differently regulate human astrocyte immune reactivity and impair mitochondrial respiration","volume":"34","author":"Russ","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2025.106803_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008784","article-title":"Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease","volume":"5","author":"Sanchez-Guajardo","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2025.106803_bb0300","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1038\/s41467-023-39060-w","article-title":"Border-associated macrophages mediate the neuroinflammatory response in an alpha-synuclein model of Parkinson disease","volume":"14","author":"Schonhoff","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2025.106803_bb0305","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1126\/science.1081297","article-title":"Inactivation of TNF signaling by rationally designed dominant-negative TNF variants","volume":"301","author":"Steed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.nbd.2025.106803_bb0310","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/ejn.14290","article-title":"Immune system responses in Parkinson\u2019s disease: early and dynamic","volume":"49","author":"Tansey","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106803_bb0315","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.nbd.2025.106803_bb0320","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1093\/brain\/awr203","article-title":"Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-kappaB","volume":"134","author":"Taoufik","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.106803_bb0325","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.1523\/JNEUROSCI.1636-16.2016","article-title":"Anti-inflammatory modulation of microglia via CD163-targeted glucocorticoids protects dopaminergic neurons in the 6-OHDA Parkinson\u2019s disease model","volume":"36","author":"Tentillier","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106803_bb0330","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","article-title":"Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease","volume":"67","author":"Theodore","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2025.106803_bb0335","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/mt.2009.142","article-title":"Dose optimization for long-term rAAV-mediated RNA interference in the nigrostriatal projection neurons","volume":"17","author":"Ulusoy","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2025.106803_bb0340","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","article-title":"Death by TNF: a road to inflammation","volume":"23","author":"van Loo","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.nbd.2025.106803_bb0345","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4614-5434-2_9","article-title":"Selective neurodegeneration, neuropathology and symptom profiles in Huntington\u2019s disease","volume":"769","author":"Waldvogel","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.nbd.2025.106803_bb0350","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0166-2236(98)01362-9","article-title":"Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias","volume":"22","author":"West","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2025.106803_bb0355","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/mds.26563","article-title":"Serum immune markers and disease progression in an incident Parkinson\u2019s disease cohort (ICICLE-PD)","volume":"31","author":"Williams-Gray","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.106803_bb0360","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2004.05.118","article-title":"Inhibition of tyrosine hydroxylase expression in alpha-synuclein-transfected dopaminergic neuronal cells","volume":"367","author":"Yu","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2025.106803_bb0365","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s40478-022-01379-8","article-title":"CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in huntington\u2019s disease","volume":"10","author":"Yu","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2025.106803_bb0370","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.4049\/jimmunol.179.3.1872","article-title":"Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection","volume":"179","author":"Zalevsky","year":"2007","journal-title":"J. Immunol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125000191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125000191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:44:25Z","timestamp":1740444265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125000191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":74,"alternative-id":["S0969996125000191"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.106803","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.10.11.617361","asserted-by":"object"}]},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripherally administered TNF inhibitor is not protective against \u03b1-synuclein-induced dopaminergic neuronal death in rats","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.106803","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106803"}}